GlaxoSmithKline, University of California, Los Angeles (UCLA) Researchers Will Work Together on New Collaborative R&D Model
Researchers from drug giant GlaxoSmithKline and the University of California, San Francisco, will work together to accelerate promising basic science in cancer, obesity and infectious diseases toward new drugs.
Specific financial terms of the deal weren't disclosed, but GlaxoSmithKline (NYSE: GSK) will give early-stage funding for academic discoveries that struggle to receive money via traditional grants.
The deal is important for a couple reasons as government funding difficulties push industry and academia closer.
Help employers find you! Check out all the jobs and post your resume.
Specific financial terms of the deal weren't disclosed, but GlaxoSmithKline (NYSE: GSK) will give early-stage funding for academic discoveries that struggle to receive money via traditional grants.
The deal is important for a couple reasons as government funding difficulties push industry and academia closer.
Help employers find you! Check out all the jobs and post your resume.